Clinical trial · Interventional
Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment
Inhaled Essential Oil Effect on Common Quality of Life Concerns During Cancer Treatment
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This single-blind, randomized controlled trial studies how well inhaled essential oils work for common quality of life concerns in patients who are undergoing cancer treatment such as chemotherapy, targeted therapy, and/or immunotherapy given through the vein (intravenously). Aromatherapy using essential oils, such as ginger essential oil, German chamomile essential oil, and bergamot essential oil, may improve quality of life issues such as nausea, anxiety, loss of appetite, and fatigue in patients undergoing treatment for cancer.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastrointestinal Cancer | Malignant Digestive System Neoplasm | ALIAS | 0.90 |
| Neuroendocrine Carcinoma | Neuroendocrine Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Skin Cancer | Malignant Skin Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Aromatherapy and Essential Oils | Procedure | — | UNRESOLVED |
| Subject Diary | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- type
- EXPERIMENTAL
- label
- Group I (bergamot essential oil)
- description
- Patients inhale 7 drops of bergamot essential oil using an essential oil administration bottle TID (morning, midday, and evening) for up to 7 days. Patients also use a journal to document symptoms, time of inhalation, and medication use TID for up to 7 days.
- interventionNames
- Procedure: Aromatherapy and Essential Oils
- Other: Subject Diary
- type
- EXPERIMENTAL
- label
- Group II (chamomile essential oil)
- description
- Patients inhale 7 drops of chamomile essential oil and complete journal as in group I.
- interventionNames
- Procedure: Aromatherapy and Essential Oils
- Other: Subject Diary
- type
- EXPERIMENTAL
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Gastrointestinal cancers, neuroendocrine cancer, or melanoma or other skin cancers * Receiving chemotherapy, targeted therapy, and/or immunotherapy * Not naive to the treatment * Must be able to read and write English Exclusion Criteria: * Allergies to ragweed, chrysanthemum, chamomile, ginger, bergamot, citrus fruits, tree nuts, perfumes * Asthma diagnosis * Patients receiving only octreotide injections * Patients receiving floxuridine (FUDR) via hepatic artery infusion (HAI) pump only
References
Publications (0)
Data not yet available